2022 Oct 21. pii: oyac215. doid: 10.1093/oncolo/oyac215.

In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma.

CHDR

Osanto S, Woei-A-Jin FJSH, Coenraad MJ, Weijl NI, Burgmans MC, Burggraaf J